KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 76 filers reported holding KRYSTAL BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $483,000 | – | 12,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
Artal Group S.A. | 412,082 | $32,991 | 1.96% |
First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |